Segment Wealth Management LLC grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 11.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,070 shares of the biotechnology company’s stock after acquiring an additional 404 shares during the period. Segment Wealth Management LLC’s holdings in Axon Enterprise were worth $3,370,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. TCTC Holdings LLC lifted its position in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC lifted its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares during the period. Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at approximately $32,000. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at approximately $31,000. Finally, Flaharty Asset Management LLC acquired a new position in shares of Axon Enterprise during the 1st quarter worth approximately $33,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, insider Jeffrey C. Kunins sold 7,891 shares of the business’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the sale, the insider directly owned 144,538 shares of the company’s stock, valued at $108,417,953.80. The trade was a 5.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the sale, the chief executive officer directly owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 49,932 shares of company stock worth $37,978,216 in the last three months. 4.40% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on Axon Enterprise
Axon Enterprise Trading Down 0.7%
Shares of AXON opened at $715.51 on Friday. The stock has a fifty day moving average of $757.79 and a two-hundred day moving average of $707.36. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The company has a market capitalization of $56.17 billion, a PE ratio of 176.67, a price-to-earnings-growth ratio of 27.98 and a beta of 1.41. Axon Enterprise, Inc has a fifty-two week low of $413.68 and a fifty-two week high of $885.91.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.Axon Enterprise’s revenue was up 32.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What is the Shanghai Stock Exchange Composite Index?
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- Transportation Stocks Investing
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Best Aerospace Stocks Investing
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.